Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A multicentre, double-blind, randomised, controlled phase II/III study to evaluate the efficacy and safety of the new wound healing solution Diperoxochloric acid (DPOCl, DermaPro) in patients with venous leg ulcer (ulcus cruris)

Trial Profile

A multicentre, double-blind, randomised, controlled phase II/III study to evaluate the efficacy and safety of the new wound healing solution Diperoxochloric acid (DPOCl, DermaPro) in patients with venous leg ulcer (ulcus cruris)

Status: Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 19 Aug 2017

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Diperoxochloric acid (Primary)
  • Indications Leg ulcer
  • Focus Registrational; Therapeutic Use
  • Sponsors Dermatools

Most Recent Events

  • 10 Aug 2017 According to a CytoTools AG Media Release, this trial was terminated because the reanalysis of the batch of active substance used, due to a production error, was only 50 % of the concentration prescribed by DermaTools in the specification for the trial.
  • 12 May 2015 New trial record
  • 04 Mar 2015 Intermediate results of this trial are expected in the second quarter of 2015, according to a CytoTools media release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top